Oropharyngeal Colonization of HIV-Infected Outpatients in Taiwan by Yeast Pathogens

ABSTRACT Among 234 isolates comprising 26 different Candida species colonizing the oropharynx of 181 (54.3% of 399 surveyed) HIV-infected outpatients, 27 (11.7%) were fluconazole resistant. Antibacterial treatment was associated with increased rates of yeast colonization, while antiretroviral therapy and pneumococcal vaccination protected patients from yeast colonization.

[1]  Yun-Liang Yang,et al.  The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan. , 2010, Medical mycology.

[2]  A. Colombo,et al.  Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  Zhi-Yuan Shi,et al.  Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patients , 2008, Journal of Negative Results in BioMedicine.

[4]  Yun-Liang Yang,et al.  Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. , 2008, Diagnostic microbiology and infectious disease.

[5]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .

[6]  Hsien-Chang Chang,et al.  Identification of Medically Important Candida and Non-Candida Yeast Species by an Oligonucleotide Array , 2007, Journal of Clinical Microbiology.

[7]  Yi‐Ming Arthur Chen,et al.  HIV-1 in Taiwan , 2007, The Lancet.

[8]  Hsien-Chang Chang,et al.  Identification of Medically Important Yeast Species by Sequence Analysis of the Internal Transcribed Spacer Regions , 2006, Journal of Clinical Microbiology.

[9]  C. Hung,et al.  Effect of prolonged HAART on oral colonization with Candida and candidiasis , 2006, BMC infectious diseases.

[10]  Jih-Shin Liu,et al.  Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species , 2005, BMC infectious diseases.

[11]  L. McDonald,et al.  Colonization of Human Immunodeficiency Virus-Infected Outpatients in Taiwan with Candida Species , 2005, Journal of Clinical Microbiology.

[12]  Yun-Liang Yang,et al.  Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. , 2005, Diagnostic microbiology and infectious disease.

[13]  Yun-Liang Yang,et al.  Susceptibilities of Candida Species to Amphotericin B and Fluconazole: The Emergence of Fluconazole Resistance in Candida tropicalis , 2004, Infection Control & Hospital Epidemiology.

[14]  Yun-Liang Yang,et al.  Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. , 2003, Diagnostic microbiology and infectious disease.

[15]  J. Sobel,et al.  Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. , 2003, The Journal of infectious diseases.

[16]  G. Pizzo,et al.  Candidal carriage in the oral cavity of human immunodeficiency virus-infected subjects. , 2002, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[17]  S. Joly,et al.  Carriage Frequency, Intensity of Carriage, and Strains of Oral Yeast Species Vary in the Progression to Oral Candidiasis in Human Immunodeficiency Virus-Positive Individuals , 2002, Journal of Clinical Microbiology.

[18]  P. Hsueh,et al.  Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. , 2002, Emerging infectious diseases.

[19]  J. Lopez-Ribot,et al.  Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients , 2001, Antimicrobial Agents and Chemotherapy.

[20]  J. Limeres,et al.  Changing prevalence of human immunodeficiency virus-associated oral lesions. , 2000, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[21]  C. Yiannoutsos,et al.  Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  R. Wiesner,et al.  Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. , 1996, Transplantation.

[23]  S. Sen Gupta,et al.  Mechanisms and clinical impact of antifungal drug resistance. , 1994, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[24]  F. Odds,et al.  CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species , 1994, Journal of clinical microbiology.